Asset Details
Do you wish to reserve the book?
Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
Do you wish to request the book?
Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
2020
Overview
In the era of increasing macrolide- and quinolone-resistant Mycoplasma genitalium (MG), we report the efficacy of 2 nonquinolone antimicrobials in patients with limited treatment options. Pristinamycin + doxycycline cured 75% (95% CI, 64%–85%), and minocycline cured 71% (95% CI, 54%–85%) of cases. These data provide useful estimates to inform clinical practice.
Publisher
Oxford University Press
Subject
